NON-INVASIVE LONG-TERM ECG MONITORING VERSUS LOOP RECORDER IMPLANTATION FOR MANAGEMENT OF ATRIAL FIBRILLATION: A PILOT STUDY
https://doi.org/ 10.25760/VA-2018-94-5-10.
Abstract
To assess efficacy of long-term non-invasive continuous ambulatory ECG monitoring as compared with loop recorder implantation, 32 patients aged 58 years [47; 73] with paroxysmal atrial fibrillation were assessed.
About the Authors
S. E. Mamchur
ФГБНУ «НИИ комплексных проблем сердечно-сосудистых заболеваний»
Russian Federation
Russian Federation
E. A. Khomenko
ФГБНУ «НИИ комплексных проблем сердечно-сосудистых заболеваний»
Russian Federation
Russian Federation
T. Yu. Chichkova
ФГБНУ «НИИ комплексных проблем сердечно-сосудистых заболеваний»
Russian Federation
Russian Federation
M. P. Romanova
ФГБНУ «НИИ комплексных проблем сердечно-сосудистых заболеваний»
Russian Federation
Russian Federation
V. V. Evtushenko
ФГБНУ «НИИ комплексных проблем сердечно-сосудистых заболеваний»
Russian Federation
Russian Federation
O. M. Polikutina
ФГБНУ «НИИ комплексных проблем сердечно-сосудистых заболеваний»
Russian Federation
Russian Federation
References
1. AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society / C.T. January [et al.] // J. Am. Coll. Cardiol. 2014. Vol. 64 (21). P. e1-76.
2. Stroke Risk in Atrial Fibrillation Working Group. Independent predictors of stroke in patients with atrial fibrillation: a systematic review // Neurology. 2007. Vol. 69 (6). P. 546-554.
3. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association / E.C. Jauch [et al.] // Stroke. 2013. Vol. 44 (3). P. 870-947.
4. Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States / K.S. Coyne [et al.] // Value Health. 2006. Vol. 9. P. 348-356.
5. Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study / G.C. Flaker [et al.] // Am. Heart J. 2005. Vol. 149(4). P. 657-663.
6. Subclinical atrial fibrillation and the risk of stroke / J.S. Healey [et al.] // N. Engl. J. Med. 2012. Vol. 366. P. 120129.
7. Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers / A. Capucci [et al.] // J. Am. Coll. Cardiol. 2005. Vol. 46 (10). P. 1913-1920.
8. The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study / T.V. Glotzer [et al.] // Circ. Arrhythm. Electrophysiol. 2009. Vol. 2 (5). P. 474-480.
9. International Study on Syncope of Uncertain Etiology 2 (ISSUE 2) Group. Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neurally mediated syncope / M. Brignole [et al.] // Eur. Heart J. 2006. Vol. 27. P. 1085-1092.
10. Use of an implantable loop recorder to increase the diagnostic yield in unexplained syncope: results from the PICTURE registry / N. Edvardsson [et al.] // Europace. 2011. Vol. 13. P. 262-269.
11. Additional diagnostic value of very prolonged observation by implantable loop recorder in patients with unexplained syncope / T. Furukawa [et al.] // J. Cardiovasc. Electrophysiol. 2012. Vol. 23. P. 67-71.
12. The Utility of Ambulatory Electrocardiographic Monitoring for Detecting Silent Arrhythmias and Clarifying Symptom Mechanism in an Urban Elderly Population with Heart Failure and Hypertension: Clinical Implications / K.T. Hickey [et al.] // J. Atr. Fibrillation. 2010. Vol. 1(12). P. 663-674.
13. The prognostic value of T wave amplitude in lead aVR in males / S.Y Tan [et al.] // Ann. Noninvasive Electrocardiol. 2008. Vol. 13(2). P. 113-119.
14. Current Science on Consumer Use of Mobile Health for Cardiovascular Disease Prevention: A Scientific Statement From the American Heart Association / L.E. Burke [et al.] // Circulation. 2015. Vol. 132. P. 1157-1213.
15. Использование имплантируемых мониторов эКГ для диагностики причин синкопальных состояний неизвестного генеза у подростков: ближайшие результаты / С.Е. Мамчур [и др.] // Комплексные проблемы сердечно-сосудистых заболеваний. 2016. № 4. С. 110-115.
16. Use of a Noninvasive Continuous Monitoring Device in the Management of Atrial Fibrillation: A Pilot Study / M.A. Rosenberg [et al.] // Pacing Clin. Electrophysiol. 2013. Vol. 36. P. 328-333.
17. Cryptogenic stroke and underlying atrial fibrillation / A. Tommaso [et al.] // N. Engl. J. Med. 2014. Vol. 370 (26). P. 2478-2486.
18. Clinical characteristics of patients with asymptomatic recurrences of atrial fibrillation in the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico-Atrial Fibrillation (GISSI-AF) trial / M. Disertori [et al.] // Am. Heart J. 2011. Vol. 162. P. 382-389.
19. Symptomatic and asymptomatic atrial fibrillation after pulmonary vein ablation and the impact on quality of life / J. Pontoppidan [et al.] // Pacing Clin. Electrophysiol. 2009. Vol. 32. P. 717-726.
20. Performance of a new leadless implantable cardiac monitor in detecting and quantifying atrial fibrillation: Results of the XPECT trial / G. Hindricks [et al.] // Circ. Arrhythm. Electrophysiol. 2010. Vol. 3(2). P. 141-147.
Review
For citations:
Mamchur S.E., Khomenko E.A., Chichkova T.Yu., Romanova M.P., Evtushenko V.V., Polikutina O.M. NON-INVASIVE LONG-TERM ECG MONITORING VERSUS LOOP RECORDER IMPLANTATION FOR MANAGEMENT OF ATRIAL FIBRILLATION: A PILOT STUDY. Journal of Arrhythmology. 2018;(94):5-10. (In Russ.) https://doi.org/ 10.25760/VA-2018-94-5-10.
Views:
277
Email this article 